Validation of severity assessment and refinement in neuroscience rat models of subarachnoid hemorrhage and cerebrovascular research
Validation of severity assessment and refinement in neuroscience rat models of subarachnoid hemorrhage and cerebrovascular research
批准号:
329689066
负责人:
Professorin Dr. Ute Lindauer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
急性脑损伤的动物模型对严重程度评估提出了特殊的挑战。脑损伤本身可能导致行为改变,如感觉和运动缺陷、认知缺陷或冲动缺陷,这些都可能影响健康测试的结果,这些测试通常用于严重程度评估。此外,需要侵入性外科手术来启动病变,这增加了由病理生理过程引起的负担。在前两个资助期内,我们使用了两种大鼠蛛网膜下腔出血(SAH)模型(细丝穿孔;枕大池血液注射),以确定最有用的措施,减少福祉,痛苦或负担,适用于大鼠急性脑损伤模型和脑血管研究模型。由于SAH模型中的死亡率极高,最能反映人类的病理生理学,因此我们还专注于识别具有快速达到人道终点或过早死亡风险的动物。在数据科学方法的支持下,我们确定了可以在动物的日常护理中实施的核心结果参数(体重和自愿轮跑,补充经典临床评分)。在开阔场地和挖洞的活动被认为是进一步有用的参数,它们的评估更耗时,并且在动物之间显示出更多的异质性结果。在第三个资助期,基于该数据集,我们将对急性期和亚急性期的两种评估的SAH模型进行跨模型分析,旨在对所产生的SAH的严重程度以及假手术动物中的相应手术方法进行分级。在所有神经科学组的跨实验室和跨模型分析中,将验证这些核心参数在研究时间尺度内的信息价值、稳健性和普遍性。我们还将在实验室间方法中专门讨论假手术对照组的暴露量。除了进一步阐述数据科学的方法,基于算法的多维方案的重复性严重性评估(SASA)的痛苦在实验过程中,以及开发的生物信息学工作流程的综合措施计划之间的比较严重性评估的研究单位将应用。根据从家庭监护和植入遥测装置获得的行为和生命参数(活动、体温、心率)数据,将通过支持向量机分类和无监督k均值聚类进行严重程度分级和早期人道终点检测的细化。最后,对于基于证据的镇痛优化,将评估卡洛芬联合长效局部麻醉的多模式方法作为丁丙诺啡的替代、非阿片类药物策略。
英文摘要
Animal models of acute brain injury pose a special challenge regarding severity assessment. The brain lesion itself may cause behavioural alterations like sensory and motor deficits, cognitive deficits, or impulse deficiency, which all may influence the outcome of tests for well-being, which are generally applied for severity assessment. In addition, invasive surgery procedures are needed for lesion initiation, which adds to the burden induced by the pathophysiological processes. Within the first two funding periods we have used two models of subarachnoid hemorrhage (SAH) in rats (filament perforation; cisterna magna blood injection) to identify most useful measures of reduced well-being, distress or burden, applicable in rat acute brain injury models and models for cerebrovascular research in general. Due to the comparably high death rate in the SAH models best reflecting the pathophysiology in humans, we additionally focused on identification of animals at risk for rapidly reaching humane endpoint or premature death. Supported by data science approaches, we have identified core outcome parameters that can be implemented in the everyday care of the animals (body weight and voluntary wheel running, supplementing the classical clinical score). Activity in open field and burrowing figured out as further useful parameters, with their assessment being more time-consuming and showing more heterogenous results between animals. In the third funding period, based on this dataset, we will perform cross-model analysis of the two assessed SAH models in the acute and sub-acute phase aiming at grading of severity of the resultant SAH as well as of the respective surgical approach in sham animals. In a cross-laboratory and cross-model analysis within all neuroscience groups, these core parameters will be validated for their informative value, robustness and generalisability within the time scales of the studies. We will also specifically address the exposure of sham operated control groups in an inter-laboratory approach. In addition to further elaborate data science approaches, the algorithm-based multidimensional scheme of RELative Severity Assessment (RELSA) for continuous quantitative monitoring of distress during the course of the experiment, as well as the developed bioinformatics work flow of composite measure schemes for comparative severity assessment between the different models within the research unit will be applied. Based on data of behavioural and vital parameters (activity, temperature, heart rate) achieved from homecage monitoring and implanted telemetric devices, severity grading and refinement of early humane endpoint detection will be performed by support vector machine classification with unsupervised k-means clustering. Finally, for evidence-based analgesia refinement, the multimodal approach of carprofen in combination with long-lasting local anaesthesia will be assessed as an alternative, non-opioid based strategy to buprenorphine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurovaskuläre Kopplung und intrakranieller Druck: Aufklärung der Ursachen des BOLD Post-Stimulus-Undershoot
-
批准号:13696986
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Professorin Dr. Ute Lindauer
-
依托单位:
Hämoglobin-abhängige Mechanismen der neurovaskulären Kopplung des Gehirns
-
批准号:14108187
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Professorin Dr. Ute Lindauer
-
依托单位:
海外基金